Your browser is no longer supported. Please, upgrade your browser.
Settings
AEMD Aethlon Medical, Inc. daily Stock Chart
AEMD [NASD]
Aethlon Medical, Inc.
Index- P/E- EPS (ttm)-0.72 Insider Own1.20% Shs Outstand15.91M Perf Week13.02%
Market Cap16.55M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float12.88M Perf Month5.17%
Income-6.00M PEG- EPS next Q- Inst Own16.80% Short Float7.75% Perf Quarter-26.76%
Sales0.39M P/S42.71 EPS this Y-42.20% Inst Trans8.66% Short Ratio1.62 Perf Half Y-49.27%
Book/sh-0.10 P/B- EPS next Y- ROA-732.00% Target Price26.00 Perf Year-77.68%
Cash/sh0.02 P/C55.15 EPS next 5Y- ROE- 52W Range0.79 - 5.17 Perf YTD-75.24%
Dividend- P/FCF- EPS past 5Y25.10% ROI-554.70% 52W High-79.88% Beta2.11
Dividend %- Quick Ratio0.90 Sales past 5Y-22.00% Gross Margin- 52W Low31.55% ATR0.07
Employees7 Current Ratio0.90 Sales Q/Q- Oper. Margin- RSI (14)47.03 Volatility6.84% 6.42%
OptionableNo Debt/Eq- EPS Q/Q24.10% Profit Margin- Rel Volume1.39 Prev Close0.97
ShortableNo LT Debt/Eq- EarningsNov 02 AMC Payout- Avg Volume613.88K Price1.04
Recom- SMA209.41% SMA50-16.16% SMA200-51.65% Volume834,756 Change7.42%
Nov-20-17Initiated H.C. Wainwright Buy $3
Nov-09-17 12:58PM  Dr. Charles J. Fisher, Jr. Joins Aethlon Medical's Board of Directors PR Newswire +10.82%
Nov-08-17 12:00PM  AEMD: Upcoming FDA Meeting Expected to Define U.S. Regulatory Pathway Zacks Small Cap Research -5.99%
Nov-02-17 04:15PM  Aethlon Medical Announces Fiscal 2018 Second Quarter Results PR Newswire
11:00AM  Aethlon Medical, Inc. to Host Earnings Call ACCESSWIRE
Oct-30-17 07:30AM  Aethlon Medical to Release Financial Results for the Second Quarter Fiscal Year 2018 and Host Conference Call on November 2, 2017 PR Newswire
Oct-23-17 08:00AM  AEMD: NCI Cancer Grant, FDAs Real World Data Zacks Small Cap Research
Oct-18-17 07:00AM  Featured Company News - iBio Announces Large-Scale Manufacturing Collaboration with Aethlon Medical ACCESSWIRE
Oct-16-17 07:15AM  iBio Announces Manufacturing Collaboration with Aethlon Medical GlobeNewswire
07:15AM  Aethlon Medical Announces Large-Scale Production Collaboration PR Newswire
Oct-12-17 10:14AM  How Does Aethlon Medical Inc (AEMD)s Prospect Stack Up Next To Its Healthcare Peers? Simply Wall St.
Oct-11-17 08:15AM  Aethlon Medical to Present at the 2017 BIO Investor Forum PR Newswire
Oct-10-17 01:27PM  Aethlon Medical Announces Compliance With Nasdaq Listing Criteria PR Newswire
Oct-02-17 06:00AM  Aethlon Medical Announces Pricing of $6 Million Public Offering PR Newswire -37.66%
Sep-14-17 07:30AM  Aethlon Medical Receives National Cancer Institute Contract Award PR Newswire
Sep-13-17 08:20AM  Today's Research Reports on Stocks to Watch: Aldeyra Therapeutics and Aethlon Medical ACCESSWIRE -12.22%
Sep-12-17 07:30AM  Aethlon Medical Receives Expedited Access Pathway Designation from FDA to Accelerate U.S. Access to the Hemopurifier® as a Treatment for Life-Threatening Viruses PR Newswire +35.13%
Sep-11-17 08:51PM  Should You Have Aethlon Medical Incs (AEMD) In Your Portfolio? Simply Wall St. +25.67%
Sep-06-17 09:12AM  Aethlon Medical to Present at the 19th Annual Rodman & Renshaw Global Investment Conference on September 11, 2017 PR Newswire +7.38%
Aug-21-17 10:00AM  AEMD: EAP Filed, Expect FDA Response By Mid-September Zacks Small Cap Research
Aug-11-17 09:02AM  Former NFL Pro Supports Study Of Brain Injuries And Dementia In Football Forbes
Aug-10-17 04:15PM  Aethlon Medical Announces Fiscal 2018 First Quarter Results PR Newswire -10.56%
01:00PM  Investor Network: Aethlon Medical, Inc. to Host Earnings Call ACCESSWIRE
Aug-03-17 07:29PM  ETFs with exposure to Aethlon Medical, Inc. : August 3, 2017 Capital Cube
08:00AM  Aethlon Medical To Release Financial Results for the First Quarter Fiscal Year 2018 and Host Conference Call on August 10, 2017 PR Newswire
Jul-19-17 07:11AM  Aethlon Medical Announces the Grant of a U.S. Patent Protecting Methods of Capturing MHC Antigen Associated Exosomes PR Newswire
Jul-07-17 07:00AM  Corporate News Blog - MedShape Divests its ExoShape(R) ACL Product Line to CONMED Accesswire
Jul-03-17 02:46PM  ETFs with exposure to Aethlon Medical, Inc. : July 3, 2017 Capital Cube
Jun-30-17 03:00PM  AEMD: Feasibility Study Validates Capture, EAP FDA Filing Is Next Zacks Small Cap Research
12:50PM  Aethlon Medical, Inc. :AEMD-US: Earnings Analysis: 2017 By the Numbers : June 30, 2017 Capital Cube
Jun-28-17 04:15PM  Aethlon Medical Announces Fiscal 2017 Results PR Newswire +10.23%
Jun-26-17 08:15AM  Aethlon Medical To Release 2017 Fiscal Year End Financial Results and Host Conference Call on June 28, 2017 PR Newswire
Jun-14-17 08:00AM  Aethlon Medical To Present Clinical Study Results at The BIO International Convention PR Newswire +50.00%
Jun-06-17 08:00AM  Aethlon Medical, Inc., Announces Upcoming Presentation and Webcast at the LD Micro Invitational Conference on June 6, 2017 PR Newswire
May-24-17 08:00AM  Aethlon to Present at the LD Micro Invitational Conference on June 6, 2017 PR Newswire -6.24%
Apr-28-17 11:00AM  AEMD: Feasibility Study Complete. FDA Discussions Expected To Follow Zacks Small Cap Research
Apr-24-17 09:25AM  Aethlon Medical Releases Shareholder Update PR Newswire
Apr-04-17 09:03AM  Aethlon Medical Discloses Tech Nation Interview On National Public Radio PR Newswire -19.47%
09:03AM  Aethlon Medical Discloses Tech Nation Interview On National Public Radio
Mar-31-17 09:17AM  AETHLON MEDICAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of
Mar-21-17 02:50PM  AETHLON MEDICAL INC Files SEC form 8-K, Other Events
Mar-14-17 05:17PM  AETHLON MEDICAL INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits +6.59%
Mar-13-17 07:15AM  Aethlon Medical Announces The Conclusion Of Hemopurifier Clinical Study PR Newswire +31.74%
Mar-08-17 09:25AM  Aethlon Medical To Present At ROTH Capital Partners 29th Annual Growth Stock Conference On March 14, 2017 PR Newswire
Mar-01-17 09:25AM  Aethlon Medical Announces the Grant of a European Patent Protecting Methods of Quantifying Exosomes PR Newswire
Feb-24-17 09:25AM  Aethlon Medical CEO Note: Bill Gates on the Threat of Bioterrorism PR Newswire
Feb-22-17 09:25AM  Aethlon Medical Reports Results of Cytomegalovirus, Epstein-Barr and Herpes Simplex Virus Studies PR Newswire
Feb-16-17 01:04PM  AETHLON MEDICAL INC Financials
Feb-15-17 09:00AM  AEMD: FDA Discussions Regarding U.S. Clearance Pathway Zacks Small Cap Research
09:00AM  AEMD: FDA Discussions Regarding U.S. Clearance Pathway
Feb-10-17 05:18PM  AETHLON MEDICAL INC Files SEC form 10-Q, Quarterly Report -9.62%
04:15PM  Aethlon Medical Announces Fiscal 2017 Third Quarter Results PR Newswire
07:07AM  Q3 2017 Aethlon Medical Inc Earnings Release - After Market Close
Feb-07-17 04:16PM  AETHLON MEDICAL INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standar
Feb-06-17 09:25AM  Aethlon Medical To Host Third Quarter Fiscal 2017 Investor Call On February 10, 2017 PR Newswire
Jan-27-17 11:00AM  AEMD: New CTE Study Largest in Ex-NFL Players
Jan-25-17 09:41AM  Aethlon Medical Inc. (AEMD) Readies CTE Blood Diagnostic Trial As Super Bowl LI Approaches at Insider Monkey
07:00AM  Researchers Announce Plans for Study of Candidate Blood Test to Detect Chronic Traumatic Encephalopathy (CTE) in Former NFL Players PR Newswire
Jan-20-17 12:43PM  ETFs with exposure to Aethlon Medical, Inc. : January 20, 2017
Jan-11-17 09:12AM  CEO Note - Clinical Study Update and a Review of 2016 Accomplishments PR Newswire
Jan-03-17 12:21PM  ETFs with exposure to Aethlon Medical, Inc. : January 3, 2017
Dec-30-16 03:06PM  AETHLON MEDICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Ob
Dec-22-16 12:46PM  ETFs with exposure to Aethlon Medical, Inc. : December 22, 2016
Dec-21-16 09:25AM  Passage of the 21st Century Cures Act and its Potential Implications on Biodefense PR Newswire
Dec-15-16 09:25AM  Aethlon Announces Initiation of Sepsis-Related Virus Study PR Newswire
Dec-08-16 02:09PM  ETFs with exposure to Aethlon Medical, Inc. : December 8, 2016
Nov-16-16 12:33PM  ETFs with exposure to Aethlon Medical, Inc. : November 16, 2016 -9.00%
Nov-14-16 11:52AM  Aethlon Medical, Inc. :AEMD-US: Earnings Analysis: Q2, 2017 By the Numbers : November 14, 2016
Nov-10-16 05:18PM  AETHLON MEDICAL INC Files SEC form 10-Q, Quarterly Report
04:15PM  Aethlon Medical Announces Fiscal 2017 Second Quarter Results PR Newswire
07:07AM  Q2 2017 Aethlon Medical Inc Earnings Release - After Market Close
Nov-03-16 09:25AM  Aethlon Medical To Host Second Quarter Fiscal 2017 Investor Call On November 10, 2016 PR Newswire
Nov-01-16 01:21PM  Aethlon Medical, Inc. (AEMD) Approaching A Major Catalyst With Hemopurifier Trial at Insider Monkey
Oct-13-16 09:11AM  Aethlon Medical Achieves DARPA Milestones, Including Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Validation PR Newswire
Oct-12-16 09:25AM  Aethlon Medical Announces Corporate Update Presentation At Next Week's 2016 Bio Investor Forum PR Newswire
Sep-20-16 09:25AM  Aethlon Medical Updates Corporate Presentation Schedule PR Newswire
Sep-12-16 09:25AM  Aethlon Medical To Present At The Rodman & Renshaw 18th Annual Global Investment Conference On September 13, 2016 PR Newswire
Sep-09-16 09:09AM  The Dilemma in Funding Zika and Other Pandemic Therapies PR Newswire
Sep-06-16 09:25AM  Aethlon Medical Announces Upcoming September Investor And Industry Conferences PR Newswire
Aug-22-16 12:20PM  Edited Transcript of AEMD earnings conference call or presentation 11-Aug-16 8:30pm GMT
Aug-18-16 10:20AM  AEMD: Q1 Results. Add Zika to List of Potential Targets -10.83%
Aug-11-16 05:18PM  AETHLON MEDICAL INC Files SEC form 10-Q, Quarterly Report +23.40%
04:15PM  Aethlon Medical Announces Fiscal 2017 First Quarter Results PR Newswire
01:05PM  5 Biohealth Stocks Rising 10% or More on News at 24/7 Wall St.
09:12AM  Aethlon Medical Announces Zika Virus Data PR Newswire
07:07AM  Q1 2017 Aethlon Medical Inc Earnings Release - Time Not Supplied
Aug-10-16 03:02PM  AETHLON MEDICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal
Aug-09-16 12:07PM  Aethlon Medical To Host First Quarter Fiscal 2017 Investor Call On August 11, 2016 PR Newswire
Jul-26-16 09:27AM  Aethlon Medical, Inc. :AEMD-US: Earnings Analysis: 2016 By the Numbers : July 26, 2016
Jul-20-16 12:06PM  ETFs with exposure to Aethlon Medical, Inc. : July 20, 2016
Jul-06-16 10:11AM  Aethlon Medical, Inc. :AEMD-US: Earnings Analysis: Q4, 2016 By the Numbers : July 6, 2016
Jul-05-16 09:45AM  AEMD: U.S. Clinical Trial Progressing, ATM Financing
Jun-30-16 11:44AM  Edited Transcript of AEMD earnings conference call or presentation 29-Jun-16 8:30pm GMT
Jun-29-16 05:18PM  AETHLON MEDICAL INC Files SEC form 10-K, Annual Report +6.79%
04:15PM  Aethlon Medical Announces Fiscal 2016 Results PR Newswire
07:07AM  Q4 2016 Aethlon Medical Inc Earnings Release - Time Not Supplied
Jun-28-16 09:15AM  Aethlon Medical Announces $12.5 Million At The Market Program PR Newswire
08:16AM  AETHLON MEDICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Secur
Jun-27-16 09:45AM  Aethlon Medical Joins Russell Microcap® Index PR Newswire
09:15AM  Aethlon Medical to Host Fourth Quarter and Full Year Fiscal 2016 Investor Call On June 29, 2016 PR Newswire
Jun-22-16 09:15AM  Aethlon Medical Set To Join Russell Microcap® Index PR Newswire +6.70%
Aethlon Medical, Inc., a medical device company, focuses on creating devices that address unmet medical needs in health and biodefense worldwide. The company is developing Aethlon Hemopurifier, a clinical-stage therapeutic device for the single-use removal of life-threatening viruses from the circulatory system of infected individuals. It is also involved in the development of exosome-based products to diagnose and monitor neurological disorders and cancer; and a therapeutic device to reduce the incidence of sepsis, a fatal bloodstream infection. The company was founded in 1991 and is based in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WALKER R AChairman, President & CEONov 10Option Exercise0.0014,9510205,437Nov 14 05:58 PM
REEVES ROBERT KEVP, Law & CAONov 10Option Exercise0.004,6740123,219Nov 14 05:52 PM
Leyendecker Ernest A. IIIEVP, ExplorationNov 10Option Exercise0.003,368023,038Nov 14 05:49 PM
Ingram Mitchell WEVP, Intl & DW Ops & Proj MgmtNov 10Option Exercise0.005,994031,126Nov 14 05:46 PM
GWIN ROBERT GEVP, Finance & CFONov 10Option Exercise0.005,994064,408Nov 14 05:43 PM
Champion Christopher OSVP, CAO and ControllerNov 10Option Exercise0.002,02107,538Nov 14 05:40 PM
Brown Daniel EEVP, US Onshore OperationsNov 10Option Exercise0.003,098021,171Nov 14 05:37 PM
GWIN ROBERT GEVP, Finance & CFONov 06Option Exercise0.003,927061,050Nov 08 04:48 PM
WALKER R AChairman, President & CEONov 06Option Exercise0.009,8380194,579Nov 08 04:40 PM
REEVES ROBERT KEVP, Law & CAONov 06Option Exercise0.003,0740119,824Nov 08 04:34 PM
Leyendecker Ernest A. IIIEVP, ExplorationNov 06Option Exercise0.001,337020,220Nov 08 04:31 PM
Brown Daniel EEVP, US Onshore OperationsNov 06Option Exercise0.001,426018,456Nov 08 04:27 PM
Ingram Mitchell WEVP, Intl & DW Ops & Proj MgmtNov 01Option Exercise0.0019,936033,482Nov 02 04:38 PM
Brown Daniel EEVP, US Onshore OperationsOct 26Option Exercise0.002,053017,564Oct 30 05:00 PM
Champion Christopher OSVP, CAO and ControllerOct 26Option Exercise0.001,69105,973Oct 30 04:57 PM
GWIN ROBERT GEVP, Finance & CFOOct 26Option Exercise0.005,3740116,381Oct 30 04:53 PM
Leyendecker Ernest A. IIIEVP, ExplorationOct 26Option Exercise0.001,932019,390Oct 30 04:48 PM
REEVES ROBERT KEVP, Law & CAOOct 26Option Exercise0.004,1910118,461Oct 30 04:44 PM
WALKER R AChairman, President & CEOOct 26Option Exercise0.0013,4030190,213Oct 30 04:40 PM
Holly Bradley JEVPOct 03Option Exercise0.0031,433045,768Oct 05 05:03 PM
Champion Christopher OSVP, CAO and ControllerJun 01Option Exercise0.001,49104,267Jun 05 04:23 PM
CHASE ANTHONY RDirectorMay 18Buy52.481,90599,96723,636May 18 04:27 PM
WALKER R AChairman, President & CEOMay 17Buy51.8219,3001,000,213176,718May 17 05:25 PM
FLUOR PETER JDirectorMay 17Buy51.8320,0001,036,556146,750May 17 05:22 PM
GORDON JOHN RDirectorMay 11Option Exercise47.203,950186,440180,375May 12 04:37 PM
Hollek Darrell EEVP, OperationsApr 27Option Exercise0.0025,762040,723May 01 05:33 PM